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Prokinetic and laxative effects of the crude
methanolic extract of Viola betonicifolia whole
plant in rodents
Naveed Muhammad1,3, Najeeb ur Rehman2, Haroon Khan3, Muhammad Saeed1* and Anwarul-Hassan Gilani2,4*
Abstract
Background: The present study was aimed to provide ethnopharmacological basis for the medicinal use of Viola
betonicifolia whole plant in indigestion and constipation.
Methods: Mice were used in in-vivo prokinetic and laxative studies while in-vitro experiments were conducted on
isolated tissues of rabbit and guinea-pig gut preparations suspended in a tissue bath to measure isotonic
contractions.
Results: The crude methanolic extract of Viola betonicifolia (VBME) showed partially atropine-sensitive prokinetic
(50 and 100 mg/kg) and laxative (30 and 100 mg/kg) activities in mice. When tested in isolated rabbit jejunum and
guinea-pig ileum, VBME caused dose-dependent contractions at 0.01-0.3 mg/mL and 0.03-5 mg/mL, respectively.
The spasmogenic effect was partially sensitive to atropine, while the presence of pyrilamine, SB203186 or
hexamethonium had no effect in both gut preparations. VBME partially inhibited acetylcholinesterase enzyme (19%)
in the in-vitro assay. The spasmodic effect of VBME was more efficacious in guinea-pig ileum than rabbit jejunum
preparation. The phytochemical analysis of the crude methanolic extract for total alkaloids and saponins revealed
that the VBME is a rich source of alkaloids and saponins.
Conclusions: This study showed the prokinetic and laxative effects of Viola betonicifolia in mice, partially mediated
through cholinergic action. The in-vitro spasmodic effect of the plant extract was also partially sensitive to atropine
indicating more than one mechanisms in the gut stimulant effect. This study provides a rationale for the medicinal
use of Viola betonicifolia in indigestion and constipation.
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Background
Viola betonicifolia belongs to family Violaceace locally
known as banafsha. It is found naturally in various coun-
tries of the world like Pakistan, India, Nepal, Srilanka,
China, Malaysia and Australia. In Pakistan, it is found in
the northern areas, like Swat, Hazara and district Dir.
The folk use of this plant includes purgative, antipyretic,
astringent, diaphoretic and anticancer. It has also been
used in the treatment of various neurological disorders
including epilepsy and insomnia [1]. Additionally, it has
been used in the treatment of sinusitis, skin and blood
disorders and pharyngitis [2]. Roots are used for kidney
diseases, pneumonia and bronchitis. Flowers are recom-
mended for the treatment of cough and colds while
leaves are useful for the treatment of boils [3].
Phytochemical study revealed the presence of sapo-
nins, flavonoids, tannins, proteins, and phenolic com-
pounds [4-6]. The plant has been reported to possess
multiple biological activities, such as nematicidal, anti-
oxidant, larvicidal, and cytotoxic [4], antipyretic, anal-
gesic and anti-inflammatory [5], and neuroprotective [6];
however, plant has not been studied for its effectiveness
in gut disorders. The current study was designed to pro-
vide scientific evidence to the ethnobotanical uses of the
plant in the treatment of constipation and indigestion
using various pharmacological models.
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Methods
Preparation of the crude extract
Whole plant (aerial part plus roots) of V. betonicifolia
was collected from Swat, Khyber Pakhtunkhwa, Pakistan,
in April 2010. Plant specimen was identified by Taxono-
mist, Department of Botany, University of Peshawar and
a specimen was deposited there in the herbarium with
voucher number 6410/Bot. The collected whole plant
(12 kg) was air dried and powdered. The powder was
extracted by maceration with methanol at room tem-
perature for 14 days with occasional shaking. The
methanolic extract was filtered and concentrated under
vacuum using rotary evaporator at low temperature (45°C)
to a thick and dark brown crude extract (VBME). The ap-
proximate yield was 22% w/w. The methanolic extract was
completely soluble in normal saline (0.9% w/v) and distilled
water for the in-vivo and in-vitro experiments, respectively.
Chemical and reagents
Acetylcholine perchlorate (ACh), atropine sulphate, car-
bamylcholine or carbachol (CCh), histamine hydrochlor-
ide, 5-hydroxytryptamine (5-HT), pyrilamine maleate
and hexamethonium chloride were purchased from
Sigma-Aldrich Chemicals Company (St Louis, MO,
USA). SB203186 (1-piperidinylethyl-1H-indole-3-carb-
oxylate) was purchased from Tocris (Ballwin, MO,
USA). Chemicals used for making physiological salt so-
lutions including potassium chloride, calcium chloride,
glucose, magnesium chloride, magnesium sulfate, potas-
sium dihydrogen phosphate, sodium bicarbonate, so-
dium dihydrogen phosphate and sodium chloride were
obtained from Merck (Darmstadt, Germany). All che-
micals used were of the analytical grade available and
solubilized in distilled water.
Animals
BALB/c mice (weighing 20–25 g, n = 96) were used for
the in-vivo prokinetic and laxative studies in such a way
that both activities comprised of eight groups of mice
(6 animals in each), while in-vitro experiments were
conducted on gut preparations from guinea-pigs
(weighing 400–600 g, n = 5) and local bred rabbits
(weighing 1–1.5 kg, n = 7) of either sex, housed at the
animal house of the Aga Khan University under the con-
trolled environment (23–25°C). The animals were kept
in their respective cages with sawdust (changed after
every 48 h) and were fasted according to the protocols
of the study. In routine, they were given tap water
ad libitum and a standard diet consisting of (g/kg): flour
380, fiber 380, molasses 12, NaCl 5.8, nutrivet L 2.5, po-
tassium metabisulfate 1.2, vegetable oil 38, fish meal 170
and powdered milk 150. The experimental protocols
were approved by the ethical committee of the Depart-
ment of Pharmacy, University of Peshawar, Peshawar,
Pakistan. All the experiments were performed in compli-
ance with the rulings of the Institute of Laboratory Ani-
mal Resources, Commission on Life Sciences, National
Research Council [7].
Phytochemical screening
The saponin contents in the crude extract were deter-
mined according to documented method [8]. Briefly, 2 g
of test samples were taken in a beaker and 50 mL of
petroleum ether was added and heated gently on water-
bath to 40°C for 5 min with regular shaking. The petrol-
eum ether was filtered and repeated the operation twice
with further 50 mL of petroleum ether. The marc obtained
was extracted with 4 × 60 mL of methanol on gentle
heating. The methanol layer was concentrated to approxi-
mately 25 mL on water-bath and 150 mL of dry acetone
was added to precipitate the saponins, which was followed
by filtration and drying in oven at 100°C for constant
weight. For quantification of total alkaloid contents the
marc obtained was acidified with 100 mL of 20% acetic
acid in ethanol and allowed to extract for 4 h. The
resulting solution was filtered, concentrated and then basi-
fied with concentrated ammonium hydroxide to pH 9
followed by precipitation. The final weight of precipitated
mass was designated as the total alkaloid contents.
In-vivo experiments
Charcoal meal GI transit test
The mice were divided into various groups (n = 6). The
group treated with saline (10 mL/kg) was served as a
negative control, while the group treated with CCh
(1 mg/ kg) served as positive control. The remaining
groups were treated with VBME (50 and 100 mg/kg, or-
ally) and atropine (10 mg/kg, intraperitoneally). After
15 min of treatment, each animal received 0.3 mL of
charcoal meal in the form of suspension in distilled
water containing 10% gum acacia and 10% vegetable
charcoal. After 30 min of the above treatments, animals
were sacrificed by cervical dislocation and the whole small
intestine was removed. The distance travelled by charcoal
was measured and the percent movement was calculated.
In order to assess the involvement of acetylcholine like
prokinetic effect of the extract and CCh, some groups
were treated with atropine (10 mg/kg, i.p.) 15 min prior to
the administration of the VBME or CCh [9].
Laxative activity test
In accordance with the previous method [10], mice
fasted for 6 h before the experiment were placed indi-
vidually in cages lined with clean filter paper. The ani-
mals were divided into eight groups (n = 6); the first
group acted as the negative control and received saline
(10 mL/kg, p.o.) and the second group received atropine
(10 mg/kg, i.p.) only. The third group received CCh
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(1 mg/kg, p.o), which served as the positive control. The
fourth and fifth groups received oral doses of 30 and
100 mg/kg of VBME, respectively. To determine the
mechanism underlying of its laxative effect, separate sets
of mice (group # 6, 7 and 8) were pretreated with atropine
(10 mg/kg, i.p.) one h before administration of the extract
or CCh. After 18 h, the feces production (total number of
feces and total number of wet feces per group) in all ani-
mals was counted, and the % increase in wet feces relative
to that of total fecal output was recorded, which was con-
sidered as the laxative effect [11].
In-vitro experiments
By following the previously described methods [12], iso-
lated gut preparations of rabbit jejunum and guinea-pig
ileum were obtained subsequent to cervical dislocation
of the animals; the abdomen was cut opened, required
tissues (jejunum and ileum) were excised and transferred
to a petri dish containing normal Tyrode’s solution con-
tinuously aerated with carbogen (a mixture of 5% carbon
dioxide and 95% oxygen). The adjacent mesenteric con-
nections of preparations were cut and cleaned off. Tissue
preparations jejunum or ileum of 2–3 cm long were
mounted in 10 mL tissue baths containing Tyrode’s solu-
tion maintained at 37°C and aerated with carbogen. The
composition of Tyrode’s solution (mM) was KCl 2.68, NaCl
136.9, MgCl2 1.05, NaHCO3 11.90, NaH2PO4 0.42, CaCl2
1.8, and glucose 5.55 (pH 7.4). A preload of one g was
applied to each tissue, and the contractile responses were
recorded using isotonic transducer 50–6360 (Harvard
Apparatus, Holliston, MA, USA) coupled with either a
student oscillograph (Harvard Apparatus) or PowerLab
(ML-845) data acquisition system (AD Instruments;
Sydney, Australia) and a computer using chart software
(version 5.3). The tissues were allowed to equilibrate for a
period of 30 min, and then stabilized with sub-maximal
concentration of acetylcholine (ACh, 0.3 μM). The tissues
were presumed stable only after the reproducibility of the
said responses. The VBME was examined later for any
spasmodic activity on jejunum and ileum preparations at
concentrations ranged from 0.01 to 5.0 mg/mL.
Acetylcholinesterase inhibition assay
The aceylcholinesterase (AChE) inhibitory activity was
measured spectrophotometrically using method of Ellman
[13]. For this purpose, an enzyme kit (DACE-100-
QuantiChrom™ Acetylcholinesterase Assay Kit) based on
the Ellman method was employed. Electric-eel AChE (type
VI-S) was used, while acetylthiocholine was used as sub-
strates of the reaction. 5,5-dithiobis[2-nitrobenzoic acid]
(DTNB) was used for the measurement of cholinesterase
activity. 140 ml of the 100 mM sodium phosphate buffer
(pH 8.0), 10 mL of DTNB (1 mmol/L), 20 mL of the crude
extract solution and 20 ml of AChE/BChE (0.05 mg/ml of
AChE and 0.2 mg/ml of BChE) solution were mixed and
incubated for 15 min at 25°C. The reaction was then initi-
ated by the addition of 10 ml of acetylthiocholine
(0.71 mM of acetylthiocholine). The hydrolysis of acetyl-
thiocholine was monitored by the formation of yellow
5-thio-2-nitrobenzoate anion as the result of the reaction
of DTNB with thiocholine, released by the enzymatic hy-
drolysis of acetylthiocholine at a wavelength of 412 nm
using a spectrophotometer (Beckman DU-600 spectro-
photometer, USA) in the quartz cuvettes (Starna, U.K., no:
1 OG 5391). The extract and the control were dissolved in
EtOH (5%). The rate of enzymatic reaction was finally
determined by Ellman equation:
Rate mols = L =minð Þ ¼ Change in absorbance per min=13; 600
All the inhibition studies were conducted in 96-well
micro-titer plates using Spectra Max 340 (Molecular De-
vices, CA, USA).
Statistical analysis
All the data expressed are expressed as mean ± standard
error of mean (S.E.M., n = number of experiments) and
the median effective concentrations (EC50 values) with
95% confidence intervals (CI). One way analysis of vari-
ance (ANOVA) followed by Dunnett’s test or unpaired
t-test was used to assess the laxative activity, while one-
way ANOVA followed by Tukey’s test was employed for
the effect of plant extract in charcoal meal transit. The
concentration-response curves (CRCs) were analyzed by
non-linear regression and two-way ANOVA followed by
Bonferroni’s post-test correction or unpaired t-test was
used for multiple comparisons of CRCs with the respect-
ive control. All the graphing, calculations and statistical
analysis were performed using GraphPad Prism 4 for win-
dows (GraphPad Software, San Diego, California, USA).
Results
Phytochemical screening
The crude methanolic extract was found a rich source of
alkaloid (7.45 mg/g) and saponins contents (7.23 mg/g).
In-vivo findings
Effect of VBME on charcoal meal intestinal transit
VBME exhibited a dose-dependent increase in the pro-
pulsive movement of charcoal meal as shown in Figure 1.
The percent movement of charcoal meal through the
small intestine after treatment with VBME was 58.33
and 79.66 at the test doses of 50 and 100 mg/kg respect-
ively, while in saline, atropine and CCh treated groups
the charcoal meal travelled 51.66, 16.3 and 92.67% re-
spectively. When VBME and CCh were restudied for
their influence on transit of charcoal meal in mice
pretreated with the intraperitoneal injection of atropine,
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all the excitatory effects were markedly reduced and no
abnormal behavior was observed in animals even afte
four hours of injection.
Laxative activity
VBME treatment produced 61.16 ± 2.18% and 86.83 ±
4.8% (n = 6) wet feces in mice at 30 and 100 mg/kg, re-
spectively. The positive control, CCh (1 mg/kg) pro-
duced 88.16 ± 3.07% wet feces, while the saline and
atropine treated groups did not form any wet feces.
When VBME (30 and 100 mg/kg) was studied for its
positive influence on wet feces in mice pretreated with
atropine, the effect declined to 36.6 ± 5.2% and 46.3 ±
11.7%, respectively; further details are shown in Table 1.
In-vitro findings
Effect of VBME on rabbit and guinea-pig gut prepa-
rations In spontaneously contracting rabbit jejunum
preparations, VBME caused a concentration-dependent
stimulant effect at 0.01-0.3 mg/mL (Figure 2A), reaching
to its maximum effect of 67.33 ± 2.67% (mean ± S.E.M;
n = 5) of ACh maximum (Figure 2B). Pretreatment of
the tissue with atropine (0.1 μM) significantly (p < 0.001)
blocked the spasmogenic effect of VBME with remaining
maximum spasmodic effect declined to 23.33 ± 2.40%
(mean ± S.E.M; n = 4), while the presence of hexametho-
nium, pyrilamine or SB203186 did not alter (P > 0.05) its
effect (Figure 2A and B).
When tested in guinea-pig ileum, VBME (0.03-5 mg/
mL) exhibited a strong spasmodic effect in this quies-
cent preparation (Figure 3A), reaching its highest 96.66
± 3.33% (mean ± S.E.M; n = 5), close the ACh maximum
(Figure 3B). The efficacy of the contractile effect of
VBME in guinea-pig ileum was found higher (p < 0.05)
than observed in rabbit jejunum preparations. When the
spasmogenic effect of VBME was redetermined in the
presence of different antagonists, it was partially blocked
in the presence of atropine with remaining maximum
spasmodic effect of 28.66 ± 2.90% (mean ± S.E.M; n = 5),
while the effect remained unchanged (p > 0.05) in the
presence of hexamethonium, pyrilamine or SB203186
(Figure 3A and B), like that observed in rabbit jejunum.
Effect on acetylcholinesterase inhibition
A weak acetylcholinesterase enzyme inhibition (19%)
was demonstrated by VBME, in the in-vitro assay.
Discussion
Keeping in view the medicinal use of Viola betonicifolia
in gut disorders, such as indigestion and constipation, its
crude extract (VBME) was tested in mice, where it pro-
pelled charcoal meal through the small intestine and in-
creased the production of wet feces, hence showing
prokinetic and laxative activities, similar to the effect of
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Figure 1 Bar diagram showing the dose-dependent effect of
crude methanolic extract of Viola betonicifolia (VBME) on the
travel of charcoal meal through small intestine of mice, in the
absence and presence of atropine. One-way ANOVA followed by
Tukey’s test. *P < 0.05, **P < 0.01 and ***P < 0.001.
Table 1 Effect of atropine on the laxative activity of the crude methanolic extract of Viola betonicifolia (VBME) in mice
Group no. Treatment Dose (mg/kg) Defecation/group Number of wet feces/group % of wet feces
1 Saline (p.o mL/kg) 10 3 ± 0.36 0 0
2 Atropine (i.p) 10 1 ± 0.63 0 0
3 Carbachol (p.o) 1 11.5 ± 0.5** 10.0 ± 0.54*** 88.16 ± 3.07
4
VBME (p.o)
30 8.3 ± 0.88** 5.1 ± 0.9* 61.16 ± 2.18
5 100 11.1 ± 1.3** 9.5 ± 71** 86.83 ± 4.8
6 Carbachol + Atropine (i.p) 1 + 10 4 ± 0.5** 0.83 ± 0.3*** 22.5 ± 10.1
7
VBME (p.o) + Atropine (i.p.)
30 + 10 5.3 ± 0.9* 1.83 ± 0.3*** 36.6 ± 5.2
8 100 + 10 4.6 ± 0.6** 2 ± 0.36*** 46.3 ± 11.7
Values shown are mean ± S.E.M, n = 6. *P < 0.05, **P < 0.01 and ***P < 0.001 show a comparison of group # 2,3,4 and 5 vs. group # 1 (One-way ANOVA followed by
Dunnett’s test), group # 5 vs. group # 2, group # 6 vs. group # 3 and group # 7 vs. group # 4 (unpaired t- test).
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carbachol, a standard cholinergic agonist and accelerator
of intestinal contents (Brown and Taylor, 2006). These
gut stimulatory actions of the extract were found partially
sensitive to atropine, a muscarinic receptor blocker [14],
indicating the presence of some ACh-like component(s) in
addition to other gut stimulant constituent(s). ACh is a
neurotransmitter of the parasympathetic nervous system
and is known to cause gastrointestinal stimulation through
the activation of muscarinic receptors [15], hence, the
presence of ACh-like constituents partly explains its medi-
cinal use in constipation and as digestive aid. To further
study the possible mode of the observed prokinetic and
laxative properties of the extract, isolated ileum prepara-
tions of mouse was used. But VBME did not show any
stimulant effect on the baseline contraction (data not
shown) of this tiny preparation. Hence, whentested in iso-
lated rabbit jejunum and guinea-pig ileum, considered
suitable preparations to study effects on gut motility [16],
VBME showed a dose-dependent gut stimulant effect,
Figure 2 Typical tracing (A) showing the effect of the crude
methanolic extract of Viola betonicifolia (VBME) and
acetylcholine (ACh) in the absence and presence of atropine
(0.1 μM) and (B) showing the dose–response curves of the
spasmogenic effect of the VBME in the absence and presence
of atropine (0.1 μM), pyrilamine (1 μM), hexamethonium
(0.3 mM) or SB203186 (1 μM), in isolated rabbit jejunum
preparations. The values shown are mean ± S.E.M of 4–7 individual
experiments and expressed as the percentage of ACh maximum
response. *P < 0.05, **P < 0.01 and ***P < 0.001 (Two-way ANOVA,
followed by bonferoni post-test correction or unpaired t-test).
Figure 3 Typical tracing (A) showing the partial atropine-
sensitive spasmogenic effect of the crude methanolic extract of
Viola betonicifolia (VBME) in comparison to acetylcholine (ACh)
in the absence and presence of atropine (0.1 μM) and (B)
showing the dose–response curves of the spasmogenic effect
of the VBME in the absence and presence of atropine (0.1 μM),
pyrilamine (1 μM), hexamethonium (0.3 mM) or SB203186
(1 μM), in isolated guinea-pig ileum preparations. The values
shown are mean ± S.E.M of 4–7 individual experiments and
expressed as the percentage of ACh maximum response. *P < 0.05,
**P < 0.01 and ***P < 0.001 (Two-way ANOVA, followed by bonferoni
post-test correction or unpaired t-test).
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partially sensitive to atropine in both preparations,
whereas, the comparable stimulatory effect of acetylcho-
line was completely inhibited in the atropine pretreated
preparations. Partial atropine-sensitive gut stimulatory
effect of VBME was also supported by acetylcholinesterase
inhibition assay, thus, showing a common mechanism of
muscarinic receptor activation along with some additional
spasmodic component(s). However, the efficacy of gut
stimulant effect was high in guinea-pig ileum than that
found in rabbit jejunum. To further study the nature of
the unknown additional spasmodic components, other
than cholinergic, the stimulant effect was restudied in the
presence of pyrilamine, a histaminic type-1 (H1) receptor
blocker [17], hexamethonium, a ganglion blocker [18] or
SB203186, a serotonergic (5-HT) receptor antagonist [19].
But VBME showed complete resistance to these antago-
nists, clearly suggesting some additional mechanism(s), in-
dependent of histamine, nicotine or 5-Hydroxytryptamine
(5-HT, serotonin) receptors activation. Other mechanisms
known for their gut stimulant property, which have not
been ruled out in this study include certain prostaglandins
[20], platelet activating factor [21], nitric-oxide-donating
or releasing compounds [22], dopaminergic antagonists
[23], cholecystokinin [23] and tachykinins [24].
Recently we have reported the anthelmintic and nem-
aticidal properties of the VBME and its subsequent solv-
ent fractions [4,25]. It is very interesting to note that
VBME possesses combination of anthelmintic and laxa-
tive activities which has the merit because the laxative
and prokinetic properties of the tested extract will be
helpful in the expulsion of worms or nematodes from
gut. Regarding the preliminary phytochemical study, the
VBME is known to be a rich source of alkaloids, flavo-
noids, phenolic compounds and saponins [5], while in
case of quantitative phytochemical profile of the plant, it
is clear from results of this study that VBME is a rich
source of alkaloids and saponins. We have recently
reported the quantification of flavonoids and phenolic
contents in various solvent fractions of this plant. The
total polyphenols were of higher in quantity in metha-
nolic extract as compared to water fraction [4]. The
presence of alkaloids and saponins as the plant constitu-
ents, which are known to possess gut stimulatory prop-
erties [26,27], may explain the gut stimulant actions of
the plant extract, though further studies are required to
know the specific chemical(s) responsible for the tested
biological activities.
The screening of methanolic extract instead of aque-
ous fraction for this study was due to the presence of
polyphenols in the methanolic extract which are mostly
responsible for such type of activities. More useful ex-
planation for not using the aqueous extract can be as-
cribed to the presence of enzyme polyphenol oxidase,
which degrades polyphenols in water extracts, whereas
in methanol they are inactive. Moreover, water is a bet-
ter medium for the occurrence of the micro-organisms
as compared to methanol [28]. Our research group is
working on isolation of active constituents from this
plant through column chromatography and we intend to
make use of HPLC at later stage and hopefully our next
publication will contain HPLC data for the isolation of
active principles from this plant.
Conclusion
This study shows that the prokinetic, laxative and spas-
modic activities of Viola betonicifolia are partially medi-
ated through cholinergic action along with some unknown
additional mechanism(s), and the pattern of activity was
confirmed in the in-vitro experiments using rabbit je-
junum and guinea-pig ileum preparations. Thus, this study
provides sound mechanistic basis for the medicinal use of
Viola betonicifolia in gastrointestinal disorders, such as in-
digestion and constipation.
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